Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 4047362, 18 pages
http://dx.doi.org/10.1155/2016/4047362
Research Article

Colonic and Hepatic Modulation by Lipoic Acid and/or N-Acetylcysteine Supplementation in Mild Ulcerative Colitis Induced by Dextran Sodium Sulfate in Rats

1Faculdade de Nutrição (FANUT), Universidade Federal de Alagoas (UFAL), Campus A. C. Simões, Tabuleiro dos Martins, 57072-970 Maceió, AL, Brazil
2Pós-Graduação em Ciências da Saúde (PPGCS/UFAL), Maceió, AL, Brazil
3Instituto de Química e Biotecnologia (IQB/UFAL), Maceió, AL, Brazil
4Laboratório de Reatividade Cardiovascular (LRC/UFAL), Maceió, AL, Brazil
5Departamento de Fisiologia e Farmacologia (DFF), Centro de Biociências (CB), Universidade Federal de Pernambuco (UFPE), Av. Prof. Moraes Rego, 1235 Cidade Universitária, 50670-901 Recife, PE, Brazil
6Rede Nordeste de Biotecnologia (RENORBIO), Recife, PE, Brazil

Received 22 June 2016; Revised 3 October 2016; Accepted 10 October 2016

Academic Editor: Karina Reyes-Gordillo

Copyright © 2016 Fabiana Andréa Moura et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Ginter, V. Simko, and V. Panakova, “Antioxidants in health and disease,” Bratislava Medical Journal, vol. 115, no. 10, pp. 603–606, 2014. View at Publisher · View at Google Scholar
  2. T. A. Malik, “Inflammatory bowel disease: historical perspective, epidemiology, and risk factors,” Surgical Clinics of North America, vol. 95, no. 6, pp. 1105–1122, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. G. G. Kaplan, “The global burden of IBD: from 2015 to 2025,” Nature Reviews Gastroenterology & Hepatology, vol. 12, no. 12, pp. 720–727, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. F. A. Moura, K. Q. de Andrade, J. C. F. dos Santos, O. R. P. Araújo, and M. O. F. Goulart, “Antioxidant therapy for treatment of inflammatory bowel disease: does it work?” Redox Biology, vol. 6, pp. 617–639, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. B. Siegmund, “Management of mild-to-moderate ulcerative colitis,” Digestive Diseases, vol. 33, supplement 1, pp. 90–94, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. R. C. Langan, P. B. Gotsch, M. A. Krafczyk, and D. D. Skillinge, “Ulcerative colitis: diagnosis and treatment,” American Family Physician, vol. 76, no. 9, pp. 1323–1330, 2007. View at Google Scholar · View at Scopus
  7. A. Dignass, R. Eliakim, F. Magro et al., “Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis,” Revista de Gastroenterologia de Mexico, vol. 79, no. 4, pp. 263–289, 2014 (Spanish). View at Google Scholar
  8. S. C. Truelove and L. J. Witts, “Cortisone in ulcerative colitis; final report on a therapeutic trial,” British Medical Journal, vol. 2, no. 4947, pp. 1041–1048, 1955. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Wieland, D. N. Frank, B. Harnke, and K. Bambha, “Systematic review: microbial dysbiosis and nonalcoholic fatty liver disease,” Alimentary Pharmacology and Therapeutics, vol. 42, no. 9, pp. 1051–1063, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Abdul-Hai, A. Abdallah, and S. D. H. Malnick, “Influence of gut bacteria on development and progression of non-alcoholic fatty liver disease,” World Journal of Hepatology, vol. 7, no. 12, pp. 1679–1684, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Jana, A. Dutta, P. Chakraborty et al., “Alpha-lipoic acid and N-acetylcysteine protects intensive swimming exercise-mediated germ-cell depletion, pro-oxidant generation, and alteration of steroidogenesis in rat testis,” Molecular Reproduction and Development, vol. 81, no. 9, pp. 833–850, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. I. G. Thakurta, M. Chattopadhyay, A. Ghosh, and S. Chakrabarti, “Dietary supplementation with N-acetyl cysteine, α-tocopherol and α-lipoic acid reduces the extent of oxidative stress and proinflammatory state in aged rat brain,” Biogerontology, vol. 13, no. 5, pp. 479–488, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. Z. Ying, T. Kampfrath, Q. Sun, S. Parthasarathy, and S. Rajagopalan, “Evidence that α-lipoic acid inhibits NF-κB activation independent of its antioxidant function,” Inflammation Research, vol. 60, no. 3, pp. 219–225, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. K. P. Shay, A. J. Michels, W. Li, A.-N. T. Kong, and T. M. Hagen, “Cap-independent Nrf2 translation is part of a lipoic acid-stimulated detoxification stress response,” Biochimica et Biophysica Acta, vol. 1823, no. 6, pp. 1102–1109, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. A. M. Sadowska, B. Manuel-y-Keenoy, and W. A. De Backer, “Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: a review,” Pulmonary Pharmacology and Therapeutics, vol. 20, no. 1, pp. 9–22, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Q. de Andrade, F. A. Moura, J. M. dos Santos, O. R. P. de Araújo, J. C. D. F. Santos, and M. O. F. Goulart, “Oxidative stress and inflammation in hepatic diseases: therapeutic possibilities of N-acetylcysteine,” International Journal of Molecular Sciences, vol. 16, no. 12, pp. 30269–30308, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. K. P. Shay, R. F. Moreau, E. J. Smith, A. R. Smith, and T. M. Hagen, “Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential,” Biochimica et Biophysica Acta (BBA)—General Subjects, vol. 1790, no. 10, pp. 1149–1160, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. F. A. Moura, K. Q. de Andrade, J. C. F. dos Santos, and M. O. F. Goulart, “Lipoic acid: its antioxidant and anti-inflammatory role and clinical applications,” Current Topics in Medicinal Chemistry, vol. 15, no. 5, pp. 458–483, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. V. L. Tatum, C. Changchit, and C. K. Chow, “Measurement of malondialdehyde by high performance liquid chromatography with fluorescence detection,” Lipids, vol. 25, no. 4, pp. 226–229, 1990. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Pick and Y. Keisari, “A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in culture,” Journal of Immunological Methods, vol. 38, no. 1-2, pp. 161–170, 1980. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Marklund and G. Marklund, “Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase,” European Journal of Biochemistry/FEBS, vol. 47, no. 3, pp. 469–474, 1974. View at Publisher · View at Google Scholar
  22. M. M. Bradford, “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding,” Analytical Biochemistry, vol. 72, no. 1-2, pp. 248–254, 1976. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Xu, A. C. Costa-Goncalves, M. Todiras et al., “Endothelial dysfunction and elevated blood pressure in Mas gene-deleted mice,” Hypertension, vol. 51, no. 2, pp. 574–580, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Flohe and W. A. Gunzler, “Assays of glutathione peroxidase,” Methods in Enzymology, vol. 105, pp. 114–121, 1984. View at Publisher · View at Google Scholar · View at Scopus
  25. P. P. Bradley, R. D. Christensen, and G. Rothstein, “Cellular and extracellular myeloperoxidase in pyogenic inflammation,” Blood, vol. 60, no. 3, pp. 618–622, 1982. View at Google Scholar · View at Scopus
  26. T. E. Tipple and L. K. Rogers, “Methods for the determination of plasma or tissue glutathione levels,” Methods in Molecular Biology, vol. 889, pp. 315–324, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. N. Amini-Shirazi, A. Hoseini, A. Ranjbar et al., “Inhibition of tumor necrosis factor and nitrosative/oxidative stresses by Ziziphora clinopoides (Kahlioti); a molecular mechanism of protection against dextran sodium sulfate-induced colitis in mice,” Toxicology Mechanisms and Methods, vol. 19, no. 2, pp. 183–189, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. I. Amrouche-Mekkioui and B. Djerdjouri, “N-acetylcysteine improves redox status, mitochondrial dysfunction, mucin-depleted crypts and epithelial hyperplasia in dextran sulfate sodium-induced oxidative colitis in mice,” European Journal of Pharmacology, vol. 691, no. 1–3, pp. 209–217, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Perše and A. Cerar, “Dextran sodium sulphate colitis mouse model: traps and tricks,” Journal of Biomedicine & Biotechnology, vol. 2012, Article ID 718617, 13 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. I. Okayasu, S. Hatakeyama, M. Yamada, T. Ohkusa, Y. Inagaki, and R. Nakaya, “A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice,” Gastroenterology, vol. 98, no. 3, pp. 694–702, 1990. View at Publisher · View at Google Scholar · View at Scopus
  31. A. K. Pandurangan, S. Ismail, Z. Saadatdoust, and N. M. Esa, “Allicin alleviates dextran sodium sulfate- (DSS-) induced ulcerative colitis in BALB/c mice,” Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 605208, 13 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Sánchez-Fidalgo, I. Villegas, A. Cárdeno et al., “Extra-virgin olive oil-enriched diet modulates DSS-colitis-associated colon carcinogenesis in mice,” Clinical Nutrition, vol. 29, no. 5, pp. 663–673, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. D. W. Wray, A. Uberoi, L. Lawrenson, D. M. Bailey, and R. S. Richardson, “Oral antioxidants and cardiovascular health in the exercise-trained and untrained elderly: a radically different outcome,” Clinical Science, vol. 116, no. 5, pp. 433–441, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. A. M. McNeilly, G. W. Davison, M. H. Murphy et al., “Effect of α-lipoic acid and exercise training on cardiovascular disease risk in obesity with impaired glucose tolerance,” Lipids in Health and Disease, vol. 10, no. 1, pp. 217–226, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Showkat, W. R. Bastnagel, and J. Q. Hudson, “Effect of α-lipoic acid on oxidative stress in end-stage renal disease patients receiving intravenous iron,” International Scholarly Research Notices: Nephrology, vol. 2014, Article ID 634515, 7 pages, 2014. View at Publisher · View at Google Scholar
  36. R. Brigelius-Flohé and M. Maiorino, “Glutathione peroxidases,” Biochimica et Biophysica Acta (BBA)—General Subjects, vol. 1830, no. 5, pp. 3289–3303, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. H. J. Forman, O. Augusto, R. Brigelius-Flohe et al., “Even free radicals should follow some rules: a Guide to free radical research terminology and methodology,” Free Radical Biology and Medicine, vol. 78, pp. 233–235, 2016. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Akman, M. Akarsu, H. Akpinar, H. Resmi, and E. Sezer, “Erythrocyte deformability and oxidative stress in inflammatory bowel disease,” Digestive Diseases and Sciences, vol. 57, no. 2, pp. 458–464, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. A. A. Te Velde, I. Pronk, F. de Kort, and P. C. F. Stokkers, “Glutathione peroxidase 2 and aquaporin 8 as new markers for colonic inflammation in experimental colitis and inflammatory bowel diseases: an important role for H2O2?” European Journal of Gastroenterology and Hepatology, vol. 20, no. 6, pp. 555–560, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Singh, A. R. Khan, and A. K. Gupta, “Role of glutathione in cancer pathophysiology and therapeutic interventions,” Journal of Experimental Therapeutics and Oncology, vol. 9, no. 4, pp. 303–316, 2012. View at Google Scholar · View at Scopus
  41. J. Pravda, “Radical induction theory of ulcerative colitis,” World Journal of Gastroenterology, vol. 11, no. 16, pp. 2371–2384, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. P. Rutgeerts, S. Vermeire, and G. Van Assche, “Biological therapies for inflammatory bowel diseases,” Gastroenterology, vol. 136, no. 4, pp. 1182–1197, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. G. Bisping, N. Lügering, S. Lütke-Brintrup et al., “Patients with inflammatory bowel disease (IBD) reveal increased induction capacity of intracellular interferon-gamma (IFN-γ) in peripheral CD8+ lymphocytes co-cultured with intestinal epithelial cells,” Clinical and Experimental Immunology, vol. 123, no. 1, pp. 15–22, 2001. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Hoves, S. W. Krause, C. Schütz et al., “Monocyte-derived human macrophages mediate anergy in allogeneic T cells and induce regulatory T cells,” The Journal of Immunology, vol. 177, no. 4, pp. 2691–2698, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. L. G. Guijarro, J. Mate, J. P. Gisbert et al., “N-acetyl-L-cysteine combined with mesalamine in the treatment of ulcerative colitis: randomized, placebo-controlled pilot study,” World Journal of Gastroenterology, vol. 14, no. 18, pp. 2851–2857, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. B. M. Fournier and C. A. Parkos, “The role of neutrophils during intestinal inflammation,” Mucosal Immunology, vol. 5, no. 4, pp. 354–366, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. X.-M. Yu and X.-F. Wang, “The in vitro proliferation and cytokine production of Vα24+Vβ11+ natural killer T cells in patients with systemic lupus erythematosus,” Chinese Medical Journal, vol. 124, no. 1, pp. 61–65, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. G. Bamias, G. Kaltsa, and S. D. Ladas, “Cytokines in the pathogenesis of ulcerative colitis,” Discovery Medicine, vol. 11, no. 60, pp. 459–467, 2011. View at Google Scholar · View at Scopus
  49. Y. You, J.-J. Fu, J. Meng, G.-D. Huang, and Y.-H. Liu, “Effect of N-acetylcysteine on the murine model of colitis induced by dextran sodium sulfate through up-regulating PON1 activity,” Digestive Diseases and Sciences, vol. 54, no. 8, pp. 1643–1650, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. P. P. Trivedi and G. B. Jena, “Role of α-lipoic acid in dextran sulfate sodium-induced ulcerative colitis in mice: studies on inflammation, oxidative stress, DNA damage and fibrosis,” Food and Chemical Toxicology, vol. 59, pp. 339–355, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. K. Karmiris, A. Avgerinos, A. Tavernaraki et al., “Prevalence and characteristics of extra-intestinal manifestations in a large cohort of greek patients with inflammatory bowel disease,” Journal of Crohn's and Colitis, vol. 10, no. 4, pp. 429–436, 2016. View at Publisher · View at Google Scholar
  52. A. Eligius Hellström, M. Färkkilä, and K.-L. Kolho, “Infliximab-induced skin manifestations in patients with inflammatory bowel disease,” Scandinavian Journal of Gastroenterology, vol. 51, no. 5, pp. 563–571, 2016. View at Publisher · View at Google Scholar · View at Scopus
  53. W. F. Balistreri, “Hepatobiliary complications of inflammatory bowel disease: overview of the issues,” Inflammatory Bowel Diseases, vol. 4, no. 3, pp. 220–224, 1998. View at Google Scholar · View at Scopus
  54. D. R. Lichtenstein, “Hepatobiliary complications of inflammatory bowel disease,” Current Gastroenterology Reports, vol. 13, no. 5, pp. 495–505, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. P. G. K. Venkatesh, U. Navaneethan, and B. Shen, “Hepatobiliary disorders and complications of inflammatory bowel disease,” Journal of Digestive Diseases, vol. 12, no. 4, pp. 245–256, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. E. Gizard, A. C. Ford, J.-P. Bronowicki, and L. Peyrin-Biroulet, “Systematic review: the epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease,” Alimentary Pharmacology & Therapeutics, vol. 40, no. 1, pp. 3–15, 2014. View at Publisher · View at Google Scholar · View at Scopus
  57. P. P. Trivedi and G. B. Jena, “Ulcerative colitis-induced hepatic damage in mice: studies on inflammation, fibrosis, oxidative DNA damage and GST-P expression,” Chemico-Biological Interactions, vol. 201, no. 1–3, pp. 19–30, 2013. View at Publisher · View at Google Scholar · View at Scopus
  58. E. O. Farombi, I. A. Adedara, O. V. Awoyemi et al., “Dietary protocatechuic acid ameliorates dextran sulphate sodium-induced ulcerative colitis and hepatotoxicity in rats,” Food Funct., vol. 7, no. 2, pp. 913–921, 2016. View at Publisher · View at Google Scholar
  59. Y.-H. Paik, J. Kim, T. Aoyama, S. De Minicis, R. Bataller, and D. A. Brenner, “Role of NADPH oxidases in liver fibrosis,” Antioxidants & Redox Signaling, vol. 20, no. 17, pp. 2854–2872, 2014. View at Publisher · View at Google Scholar · View at Scopus
  60. E. G. Giannini, R. Testa, and V. Savarino, “Liver enzyme alteration: a guide for clinicians,” Canadian Medical Association Journal, vol. 172, no. 3, pp. 367–379, 2005. View at Publisher · View at Google Scholar · View at Scopus
  61. D. R. Cremer, R. Rabeler, A. Roberts, and B. Lynch, “Safety evaluation of α-lipoic acid (ALA),” Regulatory Toxicology and Pharmacology, vol. 46, no. 1, pp. 29–41, 2006. View at Publisher · View at Google Scholar · View at Scopus
  62. L. Bonanomi and A. Gazzaniga, “Toxicological, pharmacokinetic and metabolic studies on acetylcysteine,” European Journal of Respiratory Diseases, vol. 111, pp. 45–51, 1980. View at Google Scholar · View at Scopus